• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • PRODUCT LIBRARY
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES

Pathway ACIF

April 18, 2014 By SPINEMarketGroup

Pathway ACIF
Pathway Anterior Cervical Interbody Fusion (ACIF) device compliments CustomSpine’s low-profile anterior cervical plate system. This cervical spacer was designed to offer vertebral support in the disc space while providing generous autograft containment to promote fusion. FDA cleared as an anterior cervical interbody spacer, Pathway ACIF is available in two profiles and a variety of heights to accommodate individual patient anatomy, eliminating the need for intra-operative graft creation and reducing surgery time.

  • Pathway ACIF Brochure.pdf
  • ACIF 510k Clearance Letter

Benefits: 
  • System Flexibility: Pathway ACIF is available in 0° parallel and 7°lordotic implants. Both implants are available in a range of heights from 5mm to 12mm to accommodate the patient’s individual anatomy
  • Easy to Insert: The toggle-free interface between the implant and inserter as well as the chamfered nose of the implant help facilitate easier insertion of the implant
  • Spinal Support: The large footprint optimizes implant contact with adjacent anatomy to reduce the risk of subsidence
  • Migration Resistance: Unidirectional teeth resist implant migration
  • Promotes Bone Growth: A large bone graft window allows generous amounts of autograft to be inserted in the implant facilitate bone growth with adjacent tissue
  • Enhanced Visibility: Radiolucent PEEK® Optima implant and tantalum makers optimize visibility and positioning
Indications for Use:
Pathway ACIF (anterior cervical interbody fusion) device is intended for spinal fusion procedures at one level (C2-T1) in skeletally mature patients with the following conditions: 
 

Degenerative Disc Disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies)
The device is intended to be used with supplemental spinal fixation systems that have been cleared for cervical spine.

Filed Under: NEWS

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMMED
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
logo paradigm spine
syntropiq logo

POPULAR POST LAST 90 DAYS

  • BROCHURES
  • PRODUCT LIBRARY
  • 2025 Spine Product Launches and Trends: Where is the…
  • Medical Device Correction Addresses Loss of Lordosis…
  • Expandable cages were adopted not because they fused…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • Medtronic Named in Florida Lawsuit Over Alleged…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • 2025 Update: Posterior Cervical Spine Systems Market…
  • COMPANIES
  • Johnson & Johnson Follows in Zimmer Biomet’s…
  • First CD Horizon™ ModuLeX™ Deformity Surgery in…
  • Top Six Spine Industry Milestones in 2025
  • Why Expandable Cages Sometimes Lose Lordosis After…
  • Seven Leading Augmented (AR) and Extended Reality…
  • Globus Medical Reports Preliminary Record Fourth…
  • The End of an Era: The Former LDR Medical Site in…
  • Medtronic Korea Launches Kanghui, a New…
  • Scientists Develop AxioMed Spinal Disc Replacement…
  • LAST 5 VIDEOS PUBLISHED

    1. Globus Medical: CoRoent™ Small 
    2. Spine Innovation: LOGIC Expandable 
    3. REVEL™-S: Globus Medical
    4. EXCENDER CG Bio
    5. Spineology: New OptiMesh HA Nano 

     

     

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal

    Copyright © 2026 · SPINEMarketGroup